MRK

2024Q4BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-02-04 · Fiscal end 2024-12-31 · Features as of 2025-02-03

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS1.67
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.8%
IV front—
P/C full—
P/C front—
Features as of2025-02-03

Run-up

Close—
Ret 5d+1.9%
Ret 10d+1.9%
Ret 20d+0.6%
Ret 30d-0.3%

Post-Earnings Data

Results & reaction

Print

Actual EPS
1.72Beat
Estimated EPS1.67
Actual revenue
15.6B
Surprise %+3.0%
Beat / missBeat
Beat streak 41
Beat streak 81

Reaction

1-day stock reaction+2.0%
Implied vs actual

Implied 1.8%Actual 10.8%

Gap reaction-10.8%
Day result-9.1%
Next-day upYes
Realized / IV6.05×

Post tape

Post 5d-4.6%
Post 10d-5.7%
Post volume50.8M
Vol ×10d3.98×
Vol ×20d4.48×
Post range4.4%